2Silvestre JS,Tamarat R,Senbonmatsu T,et al.Antiangiogenic effect of angiotensin Ⅱ type 2 receptor in ischemia-induced angiogenesis in mice hindlimb[J].Citc Res,2002,90(10):1072-1079.
3Gallinat S,Busche S,Schutze S,et al.AT2 receptor stimulation induces generation of ceramides in PC21W cells[J].FEBS Lett,1999,443(1):75-79.
4Jalowy A,Schulz R,Dorge H,et al.Infarct size reduction by AT1-receptor blockade through a signal cascade of AT2-receptor activation,bradykinin and prostaglandins in pigs[J].J Am Coll Cardiol,1998,32(6):1787-1796.
5Yang Z,Bove CM,French BA,et al.Angiotensin Ⅱ type 2 receptor overexpression preserves left ventricular function after myocardial infarction[J].Circulation,2002,106(1):106-111.
6Adachi Y,Saito Y,Kishimoto I,et al.Angiotensin Ⅱ type 2 receptor deficiency exacerbates heart failure and reduces survival after acute myocardial infarction in mice[J].Circulation,2003,107(19):2406-2408.
7Wang LX,Ideishi M,Yahiro E,et al.Mechanism of the cardioprotective effect of inhibition of the renin-angiotensin system on ischemia/reperfusion-induced myocardial injury[J].Hypertens Res,2001,24 (2):179-187.
8de Gasparo M,Catt KJ,Inagami T,et al.International union of pharmacology.ⅩⅩⅢ.The angiotensin Ⅱ receptors[J].Pharmacol Rev,2000,52(3):415-472.
9Stoll M,Unger T.Angiotensin and its AT2 receptor:new insights into an old system[J].Regul Pept,2001,99(2-3):175-182.
10Utsunomiya H,Nakamura M,Kakudo K,et al.Angiotensin Ⅱ AT2 receptor localization in cardiovascular tissues by its antibody developed in AT2 gene-deleted mice[J].Regul Pept,2005,126 (3):155-161.
2Di Zhang A,Nguyen Dinh Cat A,Soukaseum C,et al.Cross-talk between mineralocorticoid and angiotensin II signaling for cardiac remodeling.Hypertension,2008,52:1060-1067.
3Jugdutt BI.Clinical effectiveness of telmisartan alone or in combination therapy for controlling blood pressure and vascular risk in the elderly.Clin Interv Aging,2010,5:403-416.
4Devereux RB,Alonso DR,Lutas EM,et al.Echocardiographic assessment of left ventricular hypertrophy:comparison to necropsy findings.Am J Cardiol,1986,57:450-458.
5Devereux RB,Casale PN,Kligfield P,et al.Performance of primary and derived M-mode echocardiographic measurements for detection of left ventricular hypertrophy in necropsied subjects and in patients with systemic hypertension,mitral regurgitation and dilated cardiomyopathy.Am J Cardiol,1986,57:1388-1393.
6Tai DJ,Lim TW,James MT,et al.Cardiovascular effects of angiotensin converting enzyme inhibition or angiotensin receptor blockade in hemodialysis:a meta-analysis.Clin J Am Soc Nephrol,2010,5:623-630.
7Lethen H,Tries HP,Kersting S,et al.Improvement of coronary microvascular function after Angiotensin receptor blocker treatment with irbesartan in patients with systemic hypertension.J Clin Hypertens,2011,13:155-161.
8Shi L,Mao C,Thornton SN,et al.Effects of intracerebroventricular losartan on AngⅡ-mediated pressor responses and c-fos expression in near-term ovine fetus.J Comp Neurol,2005,493:571-579.
9Agarwal D, Welsch MA, Keller JN, et al. Chronic exercise modulates RAS components and improves balance between pro- and anti-inflamma- tory cytokines in the brain of SHR [ J]. Basic Res Cardiol, 2011, 106 (6) :1069-1085.
10Kohzuki M, Yasujima M, Kanazawa M, et al. Antihypertensive and re- nal-protective effects of losartan in streptozotocin diabetic rats [ J ]. J Hy- pertens, 1995, 13( 1 ) :97-103.
